The Vision Therapy Software segmentation by application distinguishes five primary use‑cases that collectively shape market revenue. Pediatric Vision Therapy accounts for the largest share, roughly 40%, driven by school‑based screening programs and increasing prevalence of amblyopia, which fuels demand for age‑specific diagnostic and treatment modules. Adult Vision Therapy follows with an estimated 30% contribution, reflecting rising awareness of binocular vision disorders among working‑age populations and the integration of software into optometric practices. Sports Vision Enhancement occupies about 15% of the market; its growth is propelled by professional and amateur athletes seeking performance‑oriented visual training, prompting vendors to develop sport‑specific algorithms. Occupational Vision Training represents 10%, catering to industries such as aviation, manufacturing, and cybersecurity where visual acuity directly impacts safety and productivity; this segment benefits from corporate wellness budgets. Finally, Research & Clinical Trials comprise the remaining 5%, providing a niche but critical source of revenue through licensing of advanced analytics and data‑capture capabilities to academic institutions and pharmaceutical studies. Together, these application categories define the overall market size and guide strategic investment.